Vanderbilt Medical Center Seeking Volunteers for New HIV Vaccine

by Bill Snyder

Vanderbilt University Medical Center is recruiting healthy volunteers for the second phase of testing of a novel HIV vaccine regimen that also is being studied in AIDS-battered countries around the world.

The regimen consists of two vaccines containing synthetically modified genes from three subtypes of the AIDS-causing human immunodeficiency virus (HIV). These subtypes are responsible for about 85 percent of HIV infections worldwide.

"This is the first Phase II study of a vaccine candidate that is broadly relevant to the global AIDS pandemic," Gary Nabel, M.D., Ph.D., director of the federal Vaccine Research Center, said in a news release. A Phase II study is designed to test whether the vaccines are safe and well tolerated, and whether they cause an immune response.

Studies in primates suggest that these vaccines may not prevent HIV infection but may modify infection so that people do not develop AIDS and are much less likely to transmit the virus to others, said Peter F. Wright, M.D., director of the Division of Pediatric Infectious Diseases, who is leading the Vanderbilt study.

The Vanderbilt researchers are seeking 26 healthy adults between the ages of 18 and 50 who are not infected with HIV. Women who are pregnant, breastfeeding or planning to become pregnant are not eligible for the study.

Participants will be divided into two groups. One group will receive four injections of the two vaccines over six months. The other, which will serve as a control group, will receive injections of placebo (sterile salt water). Study participants will be followed for six months after the last injection.

The vaccinations cannot cause HIV infection, because they are made from gene fragments, not live virus or HIV-infected cells.

In previous studies, some subjects reported mild to moderate symptoms after the injections, including pain at the injection site, fatigue, headache and superficial skin lesions, but in most cases these symptoms were short-lived.

The vaccines were developed by scientists at the Dale and Betty Bumpers Vaccine Research Center, part of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. They will be tested in about 480 people from three African nations, Brazil, Haiti and Jamaica, as well as six U.S. medical centers.

For more information or to volunteer for the study, contact Joshua Barnes in the Vanderbilt HIV Vaccine Program at (615)-322-HOPE (4673) or

WhistlePig + Alfa Romeo F1

SHOREHAM, VT (September 13, 2023) — WhistlePig Whiskey, the leaders in independent craft whiskey, and Alfa Romeo F1 Team Stake are waving the checkered flag on a legend-worthy release that’s taking whiskey to G-Force levels. The Limited Edition PiggyBack Legends Series: Alfa Romeo F1 Team Stake Barrel is a high Rye Whiskey selected by the Alfa Romeo F1 Team Stake drivers, with barrels trialed in their wind tunnel to ensure a thrilling taste in every sip.

The third iteration in WhistlePig’s Single Barrel PiggyBack Legends Series, the Alfa Romeo F1 Team Stake Barrel is bottled at 96.77 proof, a nod to Valtteri Bottas’ racing number, 77, and the precision of racing. Inspired by Zhou Guanyu, the first Chinese F1 driver, this Rye Whiskey is finished with lychee and oolong tea. Herbal and floral notes of the oolong tea complement the herbaceous notes of WhistlePig’s signature PiggyBack 100% Rye, rounded out with a juicy tropical fruit finish and a touch of spice.

Keep readingShow less
by Spectrum Medical Care Center

Nurse Practitioner Ari Kravitz

When I started medical transition at 20 years old, it was very difficult to get the care I needed for hormone replacement therapy because there are very few providers trained in starting hormones for trans people, even though it’s very similar to the hormones that we prescribe to women in menopause or cisgender men with low testosterone.

I hope more providers get trained in LGBTQ+ healthcare, so they can support patients along their individual gender journey, and provide the info needed to make informed decisions about their body. I’ve personally seen my trans patients find hope and experience a better quality of life through hormone replacement therapy.

Keep readingShow less

Descanso Resort swimming pool and lounge area

Descanso Resort, Palm Springs' premier destination for gay men, just received Tripadvisor's highest honor, a Travelers' Choice "Best of the Best" award for 2023. Based on guests' reviews and ratings, fewer than 1% of Tripadvisor's 8 million listings around the world receive the coveted "Best of the Best" designation. Descanso ranked 12th in the top 25 small inns and hotels category in the United States. Quite an accomplishment!

Open less than two years, Descanso Resort offers gay men a relaxing and luxurious boutique hotel experience just minutes away from Palm Springs' buzziest restaurants, nightclubs, and shopping. Descanso has quickly established itself as a top destination for sophisticated gay travelers, earning hundreds of 5-star guest reviews and consistently ranking in Trapadvisor's top positions alongside brother properties Santiago Resort and Twin Palms Resort.

Keep readingShow less